Zenas BioPharma Stock (NASDAQ: ZBIO) stock price, news, charts, stock research, profile.
You can purchase shares of Zenas BioPharma (NASDAQ:ZBIO) through any online brokerage.
Other companies in Zenas BioPharma’s space includes: Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC) and Korro Bio (NASDAQ:KRRO).
Zenas BioPharma has a consensus price target of $31.75.
The stock price for Zenas BioPharma (NASDAQ: ZBIO) is $10.03 last updated December 20, 2024 at 5:17 PM EST.
A quarterly cash dividend of 0.00 per share of Class A Common Stock. The quarterly cash dividend was payable on January 2, 2020 to stockholders of record on December 24, 2019.
Zenas BioPharma’s Q4 earnings are confirmed for Sunday, February 16, 2025.
There is no upcoming split for Zenas BioPharma.
Zenas BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.